Archive: 03/12/2012

Clinical trial hits new target in war on breast cancer

Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...

FDA pledges support for med tech initiative

(AP)—The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.

page 6 from 8